Cardiologs Technologies, a Paris, France-based artificial intelligence driven platform to manage cardiac patients, raised $6.4m in Series A funding.
Backers included Idinvest, ISAI, Kurma Partners, Partech Ventures and Bpifrance.
The company, which has raised $10m in total funding, intends to use the capital to finalize and commercialize its platform in the United States and Europe.
Led by Yann Fleureau, co-founder and CEO, Cardiologs Technologies is advancing the ECG Analysis Platform, an ECG- analysis web solution powered by Artificial Intelligence (AI) that aims to enable physicians to screen for 10 arrhythmias including Atrial Fibrillation (AFib) using ambulatory ECG monitoring recordings.
In July 2017, the company obtained FDA clearance of the platform.